Free education: Improve your understanding of appropriate use of antidepressant in young people

July 28, 2026

General Practitioners in the South Eastern Melbourne catchment can take advantage of a new Australian Government-funded education program supporting the appropriate use of antidepressants and strengthen engagement with young patients aged 13–24.

The program comprises resources developed by the Quality Use of Medicines Alliance and are designed to enhance clinical capability, support effective communication and improve outcomes for young people.

The following support tools are available:

  • Whole-of-practice educational visits. Delivered virtually by a clinical facilitator, these sessions provide a practical overview of the latest evidence and can be tailored to your team’s needs
  • Shared decision-making tool
  • Clinical guide
  • On-demand webinars
  • Mini audits
  • Clinical articles

The resources are free and include CPD-accredited activities.

How to access education:

To access this education, register for a free Medcast account here, or log in with your existing details here.

More information can be found on the Quality Use of Medicines Hub (QHUB) Antidepressants in Young People topic.

Learn more

These educational materials are being evaluated by researchers from Monash University. This research has been approved by the Monash University Human Research Ethics Committee (MUHREC); project ID 50769.

Latest news

Key information for providers: Capvaxive® vaccine supply and availability

August 12, 2026
Recent vaccine supply and distribution issues have caused temporary vaccine shortages of the Capvaxive ® (pneumococcal) vaccine.

Supporting dementia prevention in primary care

August 12, 2026
Throughout July and August, all Australians aged 50 will receive a letter, from the Australian Government Department of Health, Disability and Ageing, about reducing their dementia risk. Some patients may bring the letter or a dementia risk assessment report to appointments to ask questions or seek support.

Mental Health & Better Access Quality Improvement - Activity 5

August 7, 2026
The purpose of this activity is to ensure patients with a mental health diagnosis (particularly high-risk mental health patients, e.g. bipolar disorder and a Mental Health Treatment Plan) that require phone (level C or D) and/or videoconference longer appointments (level C, D or E) are identified and proactively offered MyMedicare registration supporting continuity of care and improved outcomes.